Home603233 • SHA
add
Dashenlin Pharmaceutical Group Co Ltd
Previous close
¥18.25
Day range
¥18.16 - ¥18.64
Year range
¥13.50 - ¥19.35
Market cap
20.82B CNY
Avg Volume
7.27M
P/E ratio
18.27
Dividend yield
-
Primary exchange
SHA
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 6.55B | 2.51% |
Operating expense | 1.81B | -2.37% |
Net income | 282.83M | 41.04% |
Net profit margin | 4.32 | 37.58% |
Earnings per share | — | — |
EBITDA | 853.04M | 115.14% |
Effective tax rate | 24.05% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.61B | 15.52% |
Total assets | 26.08B | 0.78% |
Total liabilities | 17.59B | -0.92% |
Total equity | 8.49B | — |
Shares outstanding | 1.13B | — |
Price to book | 2.86 | — |
Return on assets | 4.44% | — |
Return on capital | 7.82% | — |
Cash Flow
Net change in cash
| (CNY) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 282.83M | 41.04% |
Cash from operations | 818.69M | 10.31% |
Cash from investing | -207.52M | 46.63% |
Cash from financing | -306.61M | -792.42% |
Net change in cash | 304.56M | -4.51% |
Free cash flow | 120.58M | 134.44% |
About
Founded
Feb 12, 1999
Website
Employees
43,532
